Bio Protocol climbs 131% in a week: But traders fear THIS pullback zone

ambcryptoPublished on 2025-08-23Last updated on 2025-08-24

Key Takeaways

Bio Protocol prices have broken past key resistance levels over the past three weeks. The failure to breach $0.268 on the first try indicated a potential retracement to the $0.151-$0.175 support zone.


Bio Protocol [BIO] rallied 131% in the past week and was up 14.2% over the past 24 hours, at press time. The token faced a pullback from the $0.268 resistance level, but the higher timeframe outlook remained bullish.

In other news, Bio Protocol has agreed to preliminary terms to fund an expansion of the human clinical trial. The study conducted is on the effect of brain health supplement products on humans.

Rally strengthens, but signs of exhaustion appear

BIO 1-day Chart

Source: BIO/USDT on TradingView

On the 1-day timeframe, BIO has stuck to its bullish structure for nearly two weeks now. Its move above the local high at $0.08 on the 7th of August initiated the current rally.

Trading volume stayed elevated, reflected by the OBV trending higher through August. The RSI moved into overbought territory near 74, confirming bullish momentum.

Historically, when RSI crossed 80, BIO retraced. It was possible that another such pullback would arrive. Already, the past 24 hours of trading saw BIO prices rejected from the $0.268 resistance level.

How deep could the BIO retracement go?

Bio Protocol 4-hour Chart

Source: BIO/USDT on TradingView

A set of Fibonacci retracement levels was plotted on the 4-hour chart using the recent rally from $0.12 to $0.264. It showed that the 61.8% and 78.6% levels were at $0.176 and $0.151, respectively.

Over the next few days, the moving averages could also serve as a dynamic support. Hence, traders wanting to buy BIO could keep an eye on the $0.151-$0.175 region.

Heatmap clusters reveal short-term targets

BIO Liquidation Heatmap

Source: CoinGlass

The 2-week Liquidation Heatmap showed small clusters of liquidity at $0.21-$0.216 and at $0.255. These would be the short-term price targets. A Bitcoin [BTC] correction below $115k could send BIO prices reeling.

In this scenario, the magnetic zone at $0.18, which was denser than the nearby pockets, could pull prices lower.

If BTC can climb higher over the weekend, it could boost market-wide sentiment and help BIO bulls, too.

Disclaimer: The information presented does not constitute financial, investment, trading, or other types of advice and is solely the writer’s opinion

Share

Related Reads

Uncovering the Truth About Agent Commerce, Payments, and Infrastructure

Decoding Agent Commerce, Payments, and Infrastructure: The Reality Over the past year, I've been building infrastructure for the Agent economy, engaging with major players like Stripe, Visa, Coinbase, Google, and dozens of startups. A clear conclusion emerges: true, large-scale demand does not yet exist. Startups face structural challenges. Data points illustrate this gap. Stripe's Agent commerce platform has over 1,000 merchants but only single-digit transacting agents. Visa's Agent payment token requires 9-month KYC and a $250M revenue threshold, accessible only to giants like Amazon. On-chain analysis reveals actual daily Agent transaction volume is around $17k, half of which are test transactions. The article analyzes four potential markets: **1. Agent-to-Merchant (A2M):** Current AI shopping UX is often inferior to traditional e-commerce for visual, comparison-heavy purchases (clothing, electronics). Chat interfaces are a step back. Real merchant interest is defensive "Agent Engine Optimization," fearing future obsolescence, not current demand. Potential exists in high-frequency, low-decision purchases (e.g., food delivery) or simplifying terrible UX (complex checkouts, non-native shoppers), but these require massive consumer distribution channels dominated by giants like DoorDash and Amazon. **2. Agent-to-API (A2A):** Developers already have subscriptions and billing for core APIs (compute, data). The argument for micro-payments via crypto for sub-dollar API calls is addressed by pre-paid balances today. The deeper issue is supplier resistance; major SaaS firms rely on enterprise contracts, not fractional cent pricing. Opportunity lies in the long tail of niche services, but this is a smaller market catering to developers, a historically low-paying group. **3. Agent-to-Agent (A2A):** This remains a theoretical long-term vision with near-zero current transaction volume. It involves unique challenges: discovery, trust, negotiation, dispute resolution. When it materializes, it will require a fundamentally new settlement infrastructure for high-speed, variable-value, multi-party transactions. It's a real long-term bet, but not the current market. **4. Agent-to-Finance (A2F):** This is the only category with existing, paying demand. Integrating AI into financial workflows (trading, portfolio management) is a natural evolution and enables new capabilities like autonomous rebalancing. However, competition favors incumbents with regulatory licenses, compliance infrastructure, and existing client relationships. **The Real Issue:** Why is infrastructure still being built? Incumbents can afford long-term bets, and payment companies see every problem as a nail for their payment hammer. However, payment is just one piece. The core challenge is *coordination*—orchestrating work between Agents and humans, verifying outcomes, and settling results. Payment is part of settlement, which is part of coordination. Companies that solve the coordination problem will subsume payments, not the other way around. Startups lack the infinite runway of giants and must find today's real market, which, after a year of exploration, lies outside these four categories—in an area with real, growing, and underserved activity.

marsbit4h ago

Uncovering the Truth About Agent Commerce, Payments, and Infrastructure

marsbit4h ago

Trading

Spot
Futures

Hot Articles

How to Buy BIO

Welcome to HTX.com! We've made purchasing BIO Protocol (BIO) simple and convenient. Follow our step-by-step guide to embark on your crypto journey.Step 1: Create Your HTX AccountUse your email or phone number to sign up for a free account on HTX. Experience a hassle-free registration journey and unlock all features.Get My AccountStep 2: Go to Buy Crypto and Choose Your Payment MethodCredit/Debit Card: Use your Visa or Mastercard to buy BIO Protocol (BIO) instantly.Balance: Use funds from your HTX account balance to trade seamlessly.Third Parties: We've added popular payment methods such as Google Pay and Apple Pay to enhance convenience.P2P: Trade directly with other users on HTX.Over-the-Counter (OTC): We offer tailor-made services and competitive exchange rates for traders.Step 3: Store Your BIO Protocol (BIO)After purchasing your BIO Protocol (BIO), store it in your HTX account. Alternatively, you can send it elsewhere via blockchain transfer or use it to trade other cryptocurrencies.Step 4: Trade BIO Protocol (BIO)Easily trade BIO Protocol (BIO) on HTX's spot market. Simply access your account, select your trading pair, execute your trades, and monitor in real-time. We offer a user-friendly experience for both beginners and seasoned traders.

4.5k Total ViewsPublished 2025.01.02Updated 2026.06.02

How to Buy BIO

Discussions

Welcome to the HTX Community. Here, you can stay informed about the latest platform developments and gain access to professional market insights. Users' opinions on the price of BIO (BIO) are presented below.

活动图片